Middleton & Co Increases Holding in Merck & Co (MRK); Apriem Advisors Has Boosted Its Clorox Co Del (CLX) Stake by $1.44 Million as Valuation Declined

The Clorox Company (NYSE:CLX) Logo

Apriem Advisors increased its stake in Clorox Co Del (CLX) by 39.38% based on its latest 2018Q4 regulatory filing with the SEC. Apriem Advisors bought 9,347 shares as the company’s stock declined 4.50% while stock markets rallied. The institutional investor held 33,085 shares of the specialty chemicals company at the end of 2018Q4, valued at $5.10 million, up from 23,738 at the end of the previous reported quarter. Apriem Advisors who had been investing in Clorox Co Del for a number of months, seems to be bullish on the $20.21B market cap company. The stock decreased 0.11% or $0.17 during the last trading session, reaching $157.66. About 67,910 shares traded. The Clorox Company (NYSE:CLX) has risen 21.73% since March 11, 2018 and is uptrending. It has outperformed by 17.36% the S&P500. Some Historical CLX News: 02/05/2018 – Clorox Cuts FY18 View To EPS $6.15-EPS $6.30; 12/03/2018 – MOODY’S SAYS CLOROX’S ANNOUNCED NUTRANEXT DEAL CREDIT NEG; 07/05/2018 – Clorox at Goldman Sachs Global Staples Forum Tomorrow; 14/03/2018 – Kingsford? Charcoal And Major League Baseball? Celebrate That Opening Day Is Back; 12/03/2018 – Clorox Estimates Nutranext Acquisition Will Add to EPS in FY2; 12/03/2018 – Clorox Expect Nutranext Acquisition to Close in Fiscal 4Q ending June 3; 08/05/2018 – Prebiotics and Probiotics Team Up in Renew Life’s First Organic Supplement; 24/05/2018 – Clorox: $2B Repurchase Program Replaces Current $750M Program; 02/05/2018 – Clorox cuts earnings outlook on swelling cost pressure; 15/05/2018 – Clorox Announces June 13 Webcast of Company Presentation at dbAccess Global Consumer Conference

Middleton & Co Inc increased its stake in Merck & Co Inc (MRK) by 5.43% based on its latest 2018Q4 regulatory filing with the SEC. Middleton & Co Inc bought 8,825 shares as the company’s stock rose 5.36% with the market. The institutional investor held 171,445 shares of the health care company at the end of 2018Q4, valued at $13.10 million, up from 162,620 at the end of the previous reported quarter. Middleton & Co Inc who had been investing in Merck & Co Inc for a number of months, seems to be bullish on the $208.18 billion market cap company. The stock increased 1.07% or $0.85 during the last trading session, reaching $80.65. About 1.48M shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 51.53% since March 11, 2018 and is uptrending. It has outperformed by 47.16% the S&P500. Some Historical MRK News: 06/04/2018 – Incyte’s combo therapy for skin cancer fails in late-stage study; 18/05/2018 – U.S. FDA – COMBINATION ARMS AND THE CHEMOTHERAPY ARMS OF BOTH STUDIES ALSO REMAIN OPEN; 03/05/2018 – Biotech unicorn Moderna raises another $125 million in expanded Merck partnership; 15/05/2018 – MERCK KGAA MRCG.DE CFO REAFFIRMS EXPECTS AN INCREASE AGAIN IN 2019 SALES, ADJ EBITDA; 16/04/2018 – Merck, Bristol-Myers cancer drugs both beat expectations, but Merck beats them a little more; 24/05/2018 – Eisai and Merck: FDA Has Extended Action Date for Supplemental New Drug Application for lenvatinib; 26/04/2018 – Bristol-Myers 1Q Opdivo Revenue $1.51 Billion; 08/03/2018 – STADA MAY BE INTERESTED IF MERCK CHANGES SCOPE OF ASSET SALE; 06/04/2018 – INCYTE, MERCK & CO. SAY EPACADOSTAT STUDY DID NOT MEET ENDPOINT; 06/03/2018 – BRISTOL-MYERS SQUIBB – OPDIVO ALSO WAS APPROVED FOR A SHORTER 30-MINUTE INFUSION ACROSS ALL APPROVED INDICATIONS

Investors sentiment increased to 0.88 in Q4 2018. Its up 0.02, from 0.86 in 2018Q3. It is positive, as 49 investors sold CLX shares while 259 reduced holdings. 83 funds opened positions while 187 raised stakes. 101.14 million shares or 5.58% more from 95.79 million shares in 2018Q3 were reported. Whittier Tru owns 5,570 shares. Finance invested in 0.41% or 4,185 shares. Callahan Ltd holds 0.26% or 8,000 shares in its portfolio. Clifford Swan Invest Counsel Limited Liability invested in 0.16% or 17,329 shares. Jarislowsky Fraser reported 5,950 shares. Bp Public Ltd stated it has 0.11% in The Clorox Company (NYSE:CLX). 5 are held by Winch Advisory Services Limited Liability Company. Saturna Corp owns 250,405 shares for 1.3% of their portfolio. Town Country State Bank Com Dba First Bankers Com owns 20,586 shares. The Minnesota-based Mairs And Power has invested 0% in The Clorox Company (NYSE:CLX). Security Natl invested in 652 shares or 0.04% of the stock. Monetary Management Grp Inc accumulated 1,200 shares. Moreover, Baldwin Brothers Ma has 0.05% invested in The Clorox Company (NYSE:CLX). Moreover, Dakota Wealth Mgmt has 0.37% invested in The Clorox Company (NYSE:CLX). Swiss National Bank & Trust, a Switzerland-based fund reported 889,392 shares.

Apriem Advisors, which manages about $424.33M and $284.36M US Long portfolio, decreased its stake in Annaly Cap Mgmt Inc (NYSE:NLY) by 43,900 shares to 159,155 shares, valued at $1.56M in 2018Q4, according to the filing. It also reduced its holding in Facebook Inc (NASDAQ:FB) by 32,823 shares in the quarter, leaving it with 6,168 shares, and cut its stake in Spdr S&P 500 Etf Tr (SPY).

More notable recent The Clorox Company (NYSE:CLX) news were published by: Fool.com which released: “Talking Stocks with Ben Allen, CEO of Parnassus Investments – Motley Fool” on March 04, 2019, also Fool.com with their article: “These 3 Stocks Are Due for a Dividend Increase – The Motley Fool” published on March 03, 2019, Seekingalpha.com published: “The Clorox Company (CLX) Presents on CAGNY 2019 Conference (Transcript) – Seeking Alpha” on February 23, 2019. More interesting news about The Clorox Company (NYSE:CLX) were released by: Bizjournals.com and their article: “Toyota’s new CIO on his first computer, automation’s impact on the company, and more – Dallas Business Journal” published on February 20, 2019 as well as Benzinga.com‘s news article titled: “Barron’s On: The Most Sustainable Companies In America – Benzinga” with publication date: February 10, 2019.

Since November 6, 2018, it had 0 buys, and 10 insider sales for $52.54 million activity. Barral Diego J sold 12,880 shares worth $2.03M. $25.13M worth of The Clorox Company (NYSE:CLX) shares were sold by Dorer Benno O. 18,366 shares were sold by GARNER DENISE, worth $3.00M. Costello Michael R. had sold 6,882 shares worth $1.10M. $1.63M worth of The Clorox Company (NYSE:CLX) was sold by Laszlo Matthew T. Baker Jeff had sold 3,694 shares worth $600,487.

More notable recent Merck & Co., Inc. (NYSE:MRK) news were published by: Businesswire.com which released: “Merck Begins Tender Offer to Acquire Immune Design – Business Wire” on March 05, 2019, also Seekingalpha.com with their article: “Merck’s Keytruda tops Pfizer’s Sutent in first-line kidney cancer – Seeking Alpha” published on February 19, 2019, Streetinsider.com published: “Merck (MRK) Announces LYNPARZA Received Positive EU CHMP Opinion For Use in Germline BRCA-Mutated HER2- – StreetInsider.com” on March 01, 2019. More interesting news about Merck & Co., Inc. (NYSE:MRK) were released by: Seekingalpha.com and their article: “FDA grants accelerated review for Merck’s application for Keytruda + Inlyta in first-line kidney cancer – Seeking Alpha” published on February 15, 2019 as well as Streetinsider.com‘s news article titled: “Merck (MRK) Announces EMA Adopts Positive Opinion for its KEYTRUDA for Six-Week Dosing Schedule Across All Current Monotherapy Indications – StreetInsider.com” with publication date: March 04, 2019.

Middleton & Co Inc, which manages about $602.39 million and $543.70 million US Long portfolio, decreased its stake in Oracle Corp (NYSE:ORCL) by 28,255 shares to 8,883 shares, valued at $401,000 in 2018Q4, according to the filing. It also reduced its holding in Equinix Inc (NASDAQ:EQIX) by 3,913 shares in the quarter, leaving it with 12,211 shares, and cut its stake in Danaher Corp Del (NYSE:DHR).

Investors sentiment decreased to 0.92 in Q4 2018. Its down 0.01, from 0.93 in 2018Q3. It worsened, as 37 investors sold MRK shares while 660 reduced holdings. 157 funds opened positions while 485 raised stakes. 1.94 billion shares or 3.54% more from 1.87 billion shares in 2018Q3 were reported. Stewart Patten Lc has invested 0.12% in Merck & Co., Inc. (NYSE:MRK). Birmingham Capital Al reported 2.55% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Moreover, Cambridge Trust has 2.69% invested in Merck & Co., Inc. (NYSE:MRK) for 511,118 shares. Gamco Investors Et Al invested 0.07% in Merck & Co., Inc. (NYSE:MRK). 127,227 were reported by Gradient Ltd Llc. Capital Fund Mgmt Sa has 100,526 shares. Orrstown Fin Service has 0.09% invested in Merck & Co., Inc. (NYSE:MRK) for 760 shares. Sphera Funds Mgmt Limited has invested 4.07% in Merck & Co., Inc. (NYSE:MRK). Parthenon Llc holds 2.8% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 148,577 shares. The Connecticut-based Paw Cap has invested 0.86% in Merck & Co., Inc. (NYSE:MRK). Rampart Com Ltd Liability holds 28,673 shares. Montecito Natl Bank & reported 10,830 shares. Taurus Asset Mngmt Ltd Liability Corporation invested in 6,712 shares. Terril Brothers has invested 6.5% in Merck & Co., Inc. (NYSE:MRK). Wms Prtn Limited Liability Corporation stated it has 12,740 shares.

The Clorox Company (NYSE:CLX) Institutional Positions Chart